• About
  • Licensing
  • Podcasting
  • Contact

AudioMedica.com

Medical News Interviews

  • Public Health
  • Oncology
  • Cardiovascular
  • General Medicine

GnRH Antagonist Protects Ovarian Function During Chemotherapy

0
  • by alexperjescuadmin
  • in General Medicine
  • — 2 Aug, 2007
GnRH Antagonist Protects Ovarian Function During Chemotherapy
AudioMedica News
GnRH Antagonist Protects Ovarian Function During Chemotherapy
GnRH Antagonist Protects Ovarian Function During Chemotherapy
00:00 /
RSS Feed
Share
Link
Embed

&ot&uot


Kate Stern

REFERENCE: O-144
KATE STERN, Royal Women’s Hospital, Melbourne
A potential new way of preserving ovarian function during chemotherapy for cancer could be treatment with an antagonist of gonadotropin-releasing hormone: GnRH. A pilot study from Melbourne looked at 18 young women with cancer or auto immune disease due to receive cyclophosphamide therapy. Sarah Maxwell spoke with Kate Stern and heard more about the study.

[audio:https://www.audiomedica.com/podcasting/general_medicine/070802kate_stern.mp3]
Share

Tags: antagonistchemotherapygnrh antagonistgonadotropin-releasing hormonekate sternmedicineovarian

You may also like...

  • Etravirine for HIV-1-infected Patients Failing Antiretroviral Therapy Etravirine for HIV-1-infected Patients Failing Antiretroviral Therapy 9 Aug, 2007
  • Mandeep Mehra MD COVID-19 Co-Morbidity Risks Quantified from Three Continents Survey 28 May, 2020
  • Elective Single Embryo Transfer in IVF: 13 Year Data From Sweden – reporting from European Society of Human Reproduction and Embryology 23rd Annual Meeting, Lyon, July 1-4, 2007 Elective Single Embryo Transfer in IVF: 13 Year Data From Sweden – reporting from European Society of Human Reproduction and Embryology 23rd Annual Meeting, Lyon, July 1-4, 2007 2 Jul, 2007
  • Shorter Anti-Viral Treatment for Hepatitis C: Less Effective Than Standard Regimen Shorter Anti-Viral Treatment for Hepatitis C: Less Effective Than Standard Regimen 2 Aug, 2007

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

  • Previous story Ovarian Stimulation Does Not Affect Fetal Birth Weight – reporting from 23rd Annual Conference of the European Society of Human Reproduction and Embryology, 1-4 July 2007, Lyon, France
  • Next story Visual Cervix Cancer Screening Test: Cheap and Effective in the Developing World
  • News

    • Mandeep Mehra MDCOVID-19 Co-Morbidity Risks Quantified from Three Continents SurveyMay 28, 2020
    • Ultrahypofractionated Radiation Just As Effective for Prostate CancerUltrahypofractionated Radiation Just As Effective for Prostate CancerMay 16, 2018
    • Paracetamol Poisoning: 12-hour modified acetylcysteine treatment for paracetamol poisoning reduced side effects associated with standard regimen.First evidence that genome editing made patients with AIDS more resistant to HIVMarch 8, 2014
    • Paracetamol Poisoning: 12-hour modified acetylcysteine treatment for paracetamol poisoning reduced side effects associated with standard regimen.Anticoagulation with warfarin can be beneficial in patients with atrial fibrillation and chronic kidney disease.March 7, 2014
    • Paracetamol Poisoning: 12-hour modified acetylcysteine treatment for paracetamol poisoning reduced side effects associated with standard regimen.Prostate cancer: Adult exposure to bisphenol-A linked to prostate cancer riskMarch 6, 2014
  • Related interviews

    • Microbiome Diversity Key To Survival After…
    • Ibrutinib: New Frontline Standard for Chronic…
    • Genomic-led AML Clinical Decision Making Within Seven Days
    • BRCA1/2 Ovarian Cancer—Three Years Disease Free…
    • Palbociclib Combination Prolongs Life After Breast…
  • Home
  • General Medicine
  • GnRH Antagonist Protects Ovarian Function During Chemotherapy

© Copyright 2021 AudioMedica.com. Typegrid Theme by WPBandit.